Omeros Message Board - Msg: 31195760

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Omeros

OMER 7.330

-2.5%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (432)	7/25/2017 9:31:55 AM
From: Biotech Jim	of 464

I realized this after thinking about it. I was in irrational exuberance territory. I was mulling numbers on the IgA nephropathy patients, and had the pie in the sky scenario that all is going smoothly with both iv and sq delivery of OMS721. I need progress on FDA discussions re Ph3 trial design and SPA for OMS721 in kidney and other diseases. Still waiting, as well as formulation updates on this drug candidate. I have the CEO on a short leash, and OMER will not be able to hackle me on my views of the company and the investment opportunity. Disclaimer: Not Art Doyle

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next